Nuformix plc
NFX.L · LSE
9/30/2024 | 9/30/2023 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.00 | 0.39 |
| FCF Yield | -72.09% | -21.25% | 0.00% | -23.06% |
| EV / EBITDA | -0.92 | -2.87 | 0.00 | -4.35 |
| Quality | ||||
| ROIC | -510.45% | -13.66% | 0.00% | -23.41% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 22.66% |
| Cash Conversion Ratio | 0.09 | 0.69 | 0.57 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -54.62% | -31.56% |
| Free Cash Flow Growth | 16.50% | 8.22% | 67.82% | -58.53% |
| Safety | ||||
| Net Debt / EBITDA | 0.04 | 0.35 | 0.00 | 0.38 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -693.01 | 0.00 | 2,313.87 |